These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35571549)

  • 1. Erythrodermic psoriasis in post-coronavirus disease 2019 patient.
    Batubara IS; Budianti WK
    Asia Pac Allergy; 2022 Apr; 12(2):e16. PubMed ID: 35571549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report.
    Lu X; Wang W
    Clin Cosmet Investig Dermatol; 2023; 16():1977-1981. PubMed ID: 37539023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab.
    Megna M; Ruggiero A; Salsano A; Lauletta G; Portarapillo A; Torta G; Martora F; Potestio L
    Clin Cosmet Investig Dermatol; 2023; 16():3503-3507. PubMed ID: 38077922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.
    Potestio L; Camela E; Cacciapuoti S; Fornaro L; Ruggiero A; Martora F; Battista T; Megna M
    Clin Cosmet Investig Dermatol; 2023; 16():2045-2059. PubMed ID: 37560255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab.
    Galluzzo M; D'Adamio S; Campione E; Mazzilli S; Bianchi L; Talamonti M
    J Dermatolog Treat; 2018 Sep; ():1-11. PubMed ID: 30256706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrodermic Psoriasis Treated with Golimumab: A Case Report.
    Lee WK; Kim GW; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim BS
    Ann Dermatol; 2015 Aug; 27(4):446-9. PubMed ID: 26273164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of Erythrodermic psoriasis treated with Golimumab.
    Kudsi M; Alzabibi MA; Shibani M
    Ann Med Surg (Lond); 2022 Jun; 78():103961. PubMed ID: 35734731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two cases.
    Megna M; Fabbrocini G; Ferrillo M; Cinelli E
    Dermatol Ther; 2020 Nov; 33(6):e14351. PubMed ID: 32981222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
    Singh RK; Lee KM; Ucmak D; Brodsky M; Atanelov Z; Farahnik B; Abrouk M; Nakamura M; Zhu TH; Liao W
    Psoriasis (Auckl); 2016; 6():93-104. PubMed ID: 28856115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin : A Review of its Pharmacology and Therapeutic Use.
    Pilkington T; Brogden RN
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Erythrodermic Psoriasis Flare-Up With Staphylococcus Bacteremia Secondary to COVID-19 Infection: A Case Report.
    Ali Khan Q; Khan T; Anthony MR; Farkouh CS; Abdi P; Amatul F; Ul Ain H
    Cureus; 2023 Mar; 15(3):e36418. PubMed ID: 37090395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
    Morita A; Okubo Y; Morisaki Y; Torisu-Itakura H; Umezawa Y
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):481-494. PubMed ID: 34967916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab.
    Pizzatti L; Mugheddu C; Sanna S; Atzori L; Rongioletti F
    Dermatol Ther; 2020 May; 33(3):e13348. PubMed ID: 32239791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis.
    Chen SX; Hinds BR; Goodman AM; Cohen PR
    Cureus; 2017 Dec; 9(12):e1936. PubMed ID: 29464143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrodermic psoriasis secondary to systemic corticosteroids.
    Heinrich M; Cook E; Roach J; Juarez RM; Payne D; Atkins R; Stetson C
    Proc (Bayl Univ Med Cent); 2020 Jan; 33(1):113-114. PubMed ID: 32063793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrodermic Psoriasis Managed with Risankizumab.
    Alajlan A; Madani A; Qadoumi TA; Aljaloud A; Alessa M
    Case Rep Dermatol; 2022; 14(2):219-224. PubMed ID: 36158862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrodermic psoriasis improved by Tildrakizumab.
    Trevisan G; Germi L; Naldi L
    Dermatol Reports; 2022 Nov; 14(4):9448. PubMed ID: 36483225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrodermic Psoriasis Treated with Apremilast.
    Arcilla J; Joe D; Kim J; Kim Y; Truong VN; Jaipaul N
    Dermatol Reports; 2016 Jun; 8(1):6599. PubMed ID: 27942369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of secukinumab in erythrodermic psoriasis: A single center experience.
    Bhatnagar A; Singh GK; Deshpande SK; Mitra B; Mitra D; Agrawal V; Reddy S; Patil C; Sandhu S
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S6-S12. PubMed ID: 38144608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy.
    Ellis J; Lew J; Brahmbhatt S; Gordon S; Denunzio T
    Case Rep Med; 2019; 2019():8165808. PubMed ID: 31031815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.